A collaboration between King's College London, King's College Hospital NHS Foundation Trust and Guy's and St Thomas' Hospital NHS Foundation Trust that offers equity investments with healthcare expertise for MedTech and digital startups.

KHP Ventures

The first NHS-founded and backed venture fund for digital health and MedTech.

Accelerating the future of healthcare in the UK and beyond.

We're excited to announce our investment in deepc! 

The company's platform is solving a fundamental challenge for health systems, who understand the value that AI can deliver but need support navigating the technical and commercial complexities of deploying it at scale. 

deepc has proven they can partner with health systems to solve these problems for the benefit of patients and clinical teams, and we look forward to working with their fabulous team and other partners to support their growth within the NHS and beyond!

Congratulations to 52North - creators of Neutrocheck®, one of three KHP Ventures portfolio companies to be accepted onto The Cedars-Sinai Accelerator’s ninth class.

Through their innovative neutrocheck solution, 52North are drastically reducing unnecessary hospitalisation for cancer patients with suspected neutropenic sepsis – one of the most common side effects of chemotherapy. 

We’ve been supporting 52 North to scale in healthcare, helping to build their networks and introduce them to experts and decision-makers, culminating in their participation in the one-week intensive innovation exchange programme in LA earlier this year.

Mireia Crispin, 52 North’s Chief Digital Officer, shares her perspectives on the companies partnership with the KHP Ventures team! ⬇️

We wish them the best of luck on the Cedars-Sinai accelerator!

iFAST Diagnostics antimicrobial susceptibility test achieved 95.3% agreement with the gold standard across a range of frontline antibiotics...in 4-5 hours as opposed to 48 hours at University Hospital Southampton NHS FT and...in 3.5 hours at The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust 

Spectacular results for team iFAST Diagnostics – a KHP Ventures portfolio company

Huge things ahead for you...🚀

Toby King 

#AMR #antimicrobialresistance #NHSefficiency

Virtual wards technology is set to have a transformative impact on how we ensure capacity in healthcare...

And Doccla are at the forefront, bringing efficient, high quality remote patient monitoring and care to the market.

With the acquisition of Open Telehealth (OTH), Doccla is rolling out its services across Europe, expanding into 10 new markets and helping make virtual wards a reality for millions more. 

Cofounder Martin Ratz explains: “What we’ve done in the UK we now want to replicate to the rest of Europe. Our ambition is to be Europe’s leading virtual hospital,” 

We're pleased to back Doccla as they scale to new heights in healthcare.

Read the full story in Sifted ⬇️

#digitalhealth #healthtech #healthcare #ClinicallyTestedCommerciallySound #FromConceptToCare

KHPV

COM:KHPVENTURES

KHP Ventures

locale

market

industry

website

linkedin

invested in

Metrics